PHAIT

Phait is a London-based biotechnology company that integrates deep pharmacological expertise with advanced artificial intelligence to improve the success rate of drug discovery and development. The company's platform focuses on predicting the safety, efficacy, and clinical outcomes of drug candidates by analyzing complex biological and pharmacological data. By prioritizing a pharmacology-first approach, Phait aims to identify high-quality leads and mitigate the risks of clinical failure early in the R&D process. The company was founded by industry veterans with significant experience in AI-driven drug discovery and traditional pharmaceutical development. Phait's technology is designed to be modality-agnostic, supporting the development of both small molecules and biologics across various therapeutic areas.